Cardiovascular
Acute Myocarditis
10
Pipeline Programs↗
6
Active Trials↗
6
Companies Involved↗
Acute Myocarditis is an early-stage landscape with 10 programs across 6 companies. The most active players are Cardiol Therapeutics Inc., Kenvue Brands, Pfizer. 3 therapies are approved with 4 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical1
Phase 1
No programs
Phase 34
Analysis
Trial Status
8
clinical trials
Not yet recruiting3 · 38%
Recruiting3 · 38%
Completed2 · 25%
Clinical Trials
Trial Activity
8 trials
Non-Steroidal Anti-Inflammatory Drugs in Acute Myocarditis
Recruiting·FFundación Centro Nacional de Investigaciones Cardiovasculares Carlos III·Phase 3·NCT06686862·150 enrolled
Value of Heart Rate Lowering Therapy in Acute Myocarditis
Recruiting·—·N/A·NCT06312891·150 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)